Junna Hou

Junna Hou

Auto-generated profile, based on publicly available information

Junna Hou


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2011 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
WCWei-Sheng Chen
Wei-Sheng Chen
JHJun-Na Hou
Jun-Na Hou
YGYu-Biao Guo
Yu-Biao Guo
HYHui-Ling Yang
Hui-Ling Yang
CXCan-Mao Xie
Can-Mao Xie
ZSZhigang She
Zhigang She
Background: Bostrycin is a novel compound isolated from marine fungi that inhibits proliferation of many cancer cells. However, the inhibitory effect of bostrycin on lung cancers has not been reported. This study is to investigate the inhibitory effects and mechanism of bostrycin on human lung cancer cells in vitro. Methods: We used MTT assay, flow cytometry, microarray, real time PCR, and Western blotting to detect the effect of bostrycin on A549 human pulmonary adenocarcinoma cells. Results: We showed a significant inhibition of cell proliferation and induction of apoptosis in bostrycin-treated lung adenocarcinoma cells. Bostrycin treatment caused cell cycle arrest in the G0/G1 phase. We also found the upregulation of microRNA-638 and microRNA-923 in bostrycin-treated cells. further, we found the downregulation of p110α and p-Akt/PKB proteins and increased activity of p27 protein after bostrycin treatment in A549 cells. Conclusions: Our study indicated that bostrycin had a significant inhibitory effect on proliferation of A549 cells. It is possible that upregulation of microRNA-638 and microRNA-923 and downregulaton of the PI3K/AKT pathway proteins played a role in induction of cell cycle arrest and apoptosis in bostrycin-treated cells.

1 January 2013 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
YGYubiao Guo
Yubiao Guo
JHJunna Hou
Junna Hou
YLYifeng Luo
Yifeng Luo
DWDujuan Wang
Dujuan Wang
Macrophage migration inhibitory factor (MIF) is important in regulating cell proliferation and apoptosis in both normal and cancerous cells, and may be important in cancer progression and metastasis. In human non-small cell lung cancer (NSCLC), the underlying mechanisms responsible for MIF-dependent regulation of cellular proliferation, and cell death remain poorly appreciated.

7 July 2017 in Cancer Biology & Therapy
Verified
Journal Article
Open access
YYYufen Tumor Yuan
Yufen Tumor Yuan
JHJunna Hou
Junna Hou
YPYunbao Pan
Yunbao Pan
Rhabdomyosarcoma (RMS) is an uncommon type of soft-tissue malignancy which mainly influences children. RMS rarely occurs in breast and little of the clinical behavior and treatment strategies were reported. Here, we describe a case of adult female patient with breast RMS. A 34-years-old Chinese woman visited to our hospital complaining palpable mass in her left breast. Seven months ago, the patient was diagnosed as lymphocytic mastitis and received surgical excision in the left breast. Five months later, she noticed a palpable mass again in the left breast. Ultrasonography suspected a malignant lesion and a diagnosis of RMS was made after segmental mastectomy and immunohistochemical staining. Therapy consisted of mastectomy and following neoadjuvant chemotherapy. The patient has remained disease free 30 months post-operatively. We should consider RMS when we see a breast mass. Tissue biopsy and immunohistochemical staining are recommended for diagnosis of RMS in young women. Oncologists should take immediate and active treatment on RMS.

1 January 2013 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
YGYubiao Guo
Yubiao Guo
JHJunna Hou
Junna Hou
YLYifeng Luo
Yifeng Luo
DWDujuan Wang
Dujuan Wang
After publication of the original article [1] it came to the authors attention that an incomplete version of figure three was published with the article. The complete figure and new figure legend are presented in this correction article.